What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Automated Antimicrobial Susceptibility Testing market?

Key drivers include rising antimicrobial resistance and the need for rapid testing solutions in clinical settings.

Which regions are leaders in the Automated Antimicrobial Susceptibility Testing market?

North America and Europe are regional leaders, driven by advanced healthcare infrastructure.

What future opportunities exist in the Automated Antimicrobial Susceptibility Testing market?

Future opportunities include emerging markets, technological advancements, and increasing adoption in veterinary medicine.

How does technology impact the Automated Antimicrobial Susceptibility Testing market?

Technology advancements, such as AI and machine learning, improve test accuracy and speed, driving market growth.

What is the current regulatory landscape for the Automated Antimicrobial Susceptibility Testing market?

The regulatory landscape is evolving, with increasing focus on standardization and validation of testing methods.

What is the future outlook for the Automated Antimicrobial Susceptibility Testing market?

The future outlook is positive, with growing demand for rapid and accurate testing solutions driving market expansion.

Automated Antimicrobial Susceptibility Testing - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Automated Antimicrobial Susceptibility Testing by Application (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals, Pathology or Diagnostic Laboratories), by Types (Consumables, Instruments), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 6.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 6.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Automated Antimicrobial Susceptibility Testing Market Overview

The Automated Antimicrobial Susceptibility Testing market refers to the industry that provides automated systems for testing the susceptibility of microorganisms to various antimicrobial agents. As the Automated Antimicrobial Susceptibility Testing market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by increasing demand for rapid and accurate diagnostic testing. The industry expansion is anticipated to be fueled by technological advancements, stringent regulations, and shifting consumer behavior, with the global market projected to grow at a CAGR of 5.5% during the forecast period from 2026 to 2033.

Loading chart…

The Automated Antimicrobial Susceptibility Testing market is influenced by key forces such as technology shifts, with the adoption of artificial intelligence and machine learning, regulations, with increasing scrutiny on antimicrobial resistance, and competitive intensity, with major players investing in research and development. The largest region in the market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and awareness of infectious diseases. As the market continues to evolve, strategic planners and business development teams must stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	20.87 million
Growth rate	CAGR of 6.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	bioMérieux; HiMedia Laboratories; Alifax Holding; Creative Diagnostics; Resistell AG; Danaher Corporation; Becton, Dickinson and Company; Thermo Fisher Scientific; Merck KGaA; Bio-Rad Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Automated Antimicrobial Susceptibility Testing market is experiencing significant growth, driven by increasing demand for rapid and accurate diagnostic solutions. The growth forecast for this market is promising, with the Automated Antimicrobial Susceptibility Testing market size expected to expand substantially in the coming years.

Growth Drivers2 items

Advances in technology, such as the development of machine learning algorithms and artificial intelligence, are driving the adoption of automated antimicrobial susceptibility testing systems, enabling faster and more accurate results.

The rising prevalence of antimicrobial resistance is fueling the demand for effective diagnostic solutions, contributing to the growth of the Automated Antimicrobial Susceptibility Testing market.

Restraints2 items

High equipment costs and maintenance expenses are limiting the adoption of automated antimicrobial susceptibility testing systems, particularly in resource-constrained settings.

The lack of standardization in testing protocols and data interpretation is hindering the widespread adoption of automated antimicrobial susceptibility testing solutions, impacting the Automated Antimicrobial Susceptibility Testing market size.

Opportunities2 items

The growing demand for point-of-care diagnostic solutions is creating opportunities for the development of portable and user-friendly automated antimicrobial susceptibility testing systems.

The increasing focus on personalized medicine is driving the need for advanced diagnostic solutions, such as automated antimicrobial susceptibility testing, to guide targeted treatment strategies.

Challenges2 items

The Automated Antimicrobial Susceptibility Testing market is highly competitive, with several established players, making it challenging for new entrants to gain market share and achieve a favorable growth forecast.

The need for regulatory compliance and adherence to evolving industry standards is a significant challenge for manufacturers of automated antimicrobial susceptibility testing systems, impacting the overall Automated Antimicrobial Susceptibility Testing market.

Market Segmentation

Loading chart…

The Automated Antimicrobial Susceptibility Testing market can be segmented based on Application, which includes Clinical Diagnostics, Research, and Pharmaceutical. The Clinical Diagnostics segment holds a significant share of the market, driven by the increasing need for accurate and rapid diagnosis of infectious diseases. The Research segment is also growing, driven by the need for antimicrobial susceptibility testing in various research applications.

Another way to segment the Automated Antimicrobial Susceptibility Testing market is by Types, which includes Manual, Semi-Automated, and Fully Automated systems. The Fully Automated systems segment is expected to dominate the market, driven by the increasing demand for high-throughput and accurate testing systems. Understanding the Automated Antimicrobial Susceptibility Testing segmentation is crucial for market players to develop targeted strategies and capitalize on the growing demand for automated antimicrobial susceptibility testing systems.

Automated Antimicrobial Susceptibility Testing Segmentation Breakdown8 items

Application

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Hospitals

Pathology or Diagnostic Laboratories

Types

Consumables

Instruments

Regional Insights

Loading chart…

The Automated Antimicrobial Susceptibility Testing market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The regional forecast indicates that Asia Pacific will be the fastest-growing region, driven by increasing adoption of automated testing systems, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high infrastructure development, and a large patient population. In Europe, drivers include stringent regulations, increasing demographics of the aging population, and a strong focus on infection control. Asia Pacific's growth is fueled by rising healthcare expenditures, growing awareness of antimicrobial resistance, and expanding access to healthcare services. Latin America's growth is driven by improving economic conditions, increasing government initiatives, and a growing middle class. The Middle East & Africa region is driven by government investments in healthcare, a growing population, and increasing disease prevalence.

Understanding these regional dynamics is crucial for stakeholders to capitalize on the Automated Antimicrobial Susceptibility Testing market growth opportunities. By analyzing the regional forecast and key drivers, companies can develop targeted strategies to expand their presence in high-growth regions and address the unique challenges and opportunities in each market.

Competitive Landscape

The Automated Antimicrobial Susceptibility Testing market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Automated Antimicrobial Susceptibility Testing competitive landscape is characterized by high competition, with companies focusing on differentiation through technology, service models, and channel strength. Global players tend to dominate the market, while local companies focus on regional expansion and customization.

Companies in the Automated Antimicrobial Susceptibility Testing market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To mitigate these risks, companies focus on competitive differentiation through technology, service models, and cost advantages. The following companies have adopted distinct strategies:

bioMérieux: regional expansion

HiMedia Laboratories: local manufacturing

Alifax Holding: premium pricing

Creative Diagnostics: innovation pipeline

Resistell AG: OEM tie-ups

Danaher Corporation: vertical integration

Key Automated Antimicrobial Susceptibility Testing Companies10 items

bioMérieux

HiMedia Laboratories

Alifax Holding

Creative Diagnostics

Resistell AG

Danaher Corporation

Becton, Dickinson and Company

Thermo Fisher Scientific

Merck KGaA

Bio-Rad Laboratories

Market Ecosystem

The Automated Antimicrobial Susceptibility Testing ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, integrators, channels, and end users. Value is created and captured as technology providers supply components and systems to integrators, who then deliver solutions to channels and ultimately to end users. This value chain analysis reveals the complex interactions and dependencies within the ecosystem.

Technology providers — supply components and systems

OEMs / manufacturers — produce automated testing equipment

System integrators / EPCs — integrate systems and provide support

Distributors / channel partners — deliver solutions to end users

Service providers / after-sales — offer maintenance and training services

End users / buyers — utilize automated testing systems in clinical settings

Regulators/standards bodies — establish guidelines and approvals for testing systems

Control points within the Automated Antimicrobial Susceptibility Testing ecosystem are primarily held by regulators and standards bodies, as their guidelines and approvals influence adoption rates. Dependency risks arise from input constraints, such as the availability of certain components, and standards that must be met. Switching costs and interoperability requirements also impact the ecosystem, as end users may be hesitant to change systems due to costs and compatibility concerns. The ecosystem's dynamics differ by region, with varying regulatory requirements and market conditions influencing the adoption and implementation of automated antimicrobial susceptibility testing systems.

Recent Industry Insights

The Automated Antimicrobial Susceptibility Testing industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading industry players have focused on enhancing technological capabilities and expanding geographical presence. Notable mergers and acquisitions have also taken place, aiming to strengthen market positions and diversify product portfolios. Furthermore, several companies have launched innovative products and technologies, improving the accuracy and efficiency of antimicrobial susceptibility testing.

Additionally, regulatory changes have driven the adoption of automated antimicrobial susceptibility testing solutions, with a growing emphasis on standardization and quality control. The shift in consumer and enterprise trends towards rapid diagnosis and personalized medicine has also fueled the demand for automated testing solutions. Funding rounds and expansions have enabled companies to invest in research and development, driving the growth of the Automated Antimicrobial Susceptibility Testing industry.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Automated Antimicrobial Susceptibility Testing market outlook is highly attractive, driven by the increasing prevalence of antimicrobial resistance and the need for rapid and accurate diagnostic solutions. The competitive intensity in this market is moderate, with key players investing heavily in research and development to improve their product offerings.

The long-term outlook for this market is positive, with the innovation landscape expected to evolve significantly over the next five years. The demand-supply balance is currently skewed towards demand, with key risk factors including regulatory challenges and reimbursement issues. However, the overall Automated Antimicrobial Susceptibility Testing market is poised for growth, driven by the increasing adoption of automated solutions in clinical laboratories.

11 items

1. Executive Summary

2. Automated Antimicrobial Susceptibility Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Automated Antimicrobial Susceptibility Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Automated Antimicrobial Susceptibility Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical and Biotechnology Companies

6.1.2. Contract Research Organizations

6.1.3. Hospitals

6.1.4. Pathology or Diagnostic Laboratories

6.2. Global Automated Antimicrobial Susceptibility Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Consumables

6.2.2. Instruments

6.3. Global Automated Antimicrobial Susceptibility Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Automated Antimicrobial Susceptibility Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Automated Antimicrobial Susceptibility Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Automated Antimicrobial Susceptibility Testing Market Competition by Key Manufacturers

8.1. Global Automated Antimicrobial Susceptibility Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Automated Antimicrobial Susceptibility Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. bioMérieux

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. HiMedia Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Alifax Holding

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Creative Diagnostics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Resistell AG

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Danaher Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Becton, Dickinson and Company

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Thermo Fisher Scientific

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Merck KGaA

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bio-Rad Laboratories

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Automated Antimicrobial Susceptibility Testing Market

Figure 4: Global Automated Antimicrobial Susceptibility Testing Market: Drivers

Figure 5: Global Automated Antimicrobial Susceptibility Testing Market: Challenges

Figure 6: Global Automated Antimicrobial Susceptibility Testing Market: Trends

Figure 7: Global Automated Antimicrobial Susceptibility Testing Market: Opportunity

Figure 8: Global Automated Antimicrobial Susceptibility Testing Market: Restraint

Figure 9: Global Automated Antimicrobial Susceptibility Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Automated Antimicrobial Susceptibility Testing Market Value (USD Million) By Region

Figure 15: Global Automated Antimicrobial Susceptibility Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Automated Antimicrobial Susceptibility Testing Market Value (USD Million) By Region

Figure 23: Global Automated Antimicrobial Susceptibility Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Automated Antimicrobial Susceptibility Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Automated Antimicrobial Susceptibility Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Automated Antimicrobial Susceptibility Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Automated Antimicrobial Susceptibility Testing Market Value (USD Million) By Region

Table 10: Global Automated Antimicrobial Susceptibility Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Automated Antimicrobial Susceptibility Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Automated Antimicrobial Susceptibility Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Automated Antimicrobial Susceptibility Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: bioMérieux Basic Information And Sales Area

Table 31: bioMérieux. Products Portfolio

Table 32: HiMedia Laboratories Basic Information And Sales Area

Table 33: HiMedia Laboratories. Products Portfolio

Table 34: Alifax Holding Basic Information And Sales Area

Table 35: Alifax Holding. Products Portfolio

Table 36: Creative Diagnostics Basic Information And Sales Area

Table 37: Creative Diagnostics. Products Portfolio

Table 38: Resistell AG Basic Information And Sales Area

Table 39: Resistell AG. Products Portfolio

Table 40: Danaher Corporation Basic Information And Sales Area

Table 41: Danaher Corporation. Products Portfolio

Table 42: Becton, Dickinson and Company Basic Information And Sales Area

Table 43: Becton, Dickinson and Company. Products Portfolio

Table 44: Thermo Fisher Scientific Basic Information And Sales Area

Table 45: Thermo Fisher Scientific. Products Portfolio

Table 46: Merck KGaA Basic Information And Sales Area

Table 47: Merck KGaA. Products Portfolio

Table 48: Bio-Rad Laboratories Basic Information And Sales Area

Table 49: Bio-Rad Laboratories. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Automated Antimicrobial Susceptibility Testing Market Value (USD Million) By Region

Table 55: Global Automated Antimicrobial Susceptibility Testing Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Automated Antimicrobial Susceptibility Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	20.87 million
Growth rate	CAGR of 6.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	bioMérieux; HiMedia Laboratories; Alifax Holding; Creative Diagnostics; Resistell AG; Danaher Corporation; Becton, Dickinson and Company; Thermo Fisher Scientific; Merck KGaA; Bio-Rad Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High equipment costs and maintenance expenses are limiting the adoption of automated antimicrobial susceptibility testing systems, particularly in resource-constrained settings.

Opportunities2 items

The growing demand for point-of-care diagnostic solutions is creating opportunities for the development of portable and user-friendly automated antimicrobial susceptibility testing systems.

The increasing focus on personalized medicine is driving the need for advanced diagnostic solutions, such as automated antimicrobial susceptibility testing, to guide targeted treatment strategies.

Challenges2 items

Market Segmentation

Loading chart…

Automated Antimicrobial Susceptibility Testing Segmentation Breakdown8 items

Application

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Hospitals

Pathology or Diagnostic Laboratories

Types

Consumables

Instruments

Regional Insights

Loading chart…

Competitive Landscape

bioMérieux: regional expansion

HiMedia Laboratories: local manufacturing

Alifax Holding: premium pricing

Creative Diagnostics: innovation pipeline

Resistell AG: OEM tie-ups

Danaher Corporation: vertical integration

Key Automated Antimicrobial Susceptibility Testing Companies10 items

bioMérieux

HiMedia Laboratories

Alifax Holding

Creative Diagnostics

Resistell AG

Danaher Corporation

Becton, Dickinson and Company

Thermo Fisher Scientific

Merck KGaA

Bio-Rad Laboratories

Market Ecosystem

Technology providers — supply components and systems

OEMs / manufacturers — produce automated testing equipment

System integrators / EPCs — integrate systems and provide support

Distributors / channel partners — deliver solutions to end users

Service providers / after-sales — offer maintenance and training services

End users / buyers — utilize automated testing systems in clinical settings

Regulators/standards bodies — establish guidelines and approvals for testing systems

Recent Industry Insights

Analyst Overview

Table of Contents